{
    "title": "Boost to new drugs pipeline lifts AstraZeneca as expiry deadline for fresh bid from US predator Pfizer approaches",
    "url": "https://www.dailymail.co.uk/money/markets/article-2839024/Boost-new-drugs-pipeline-lifts-AstraZeneca-expiry-deadline-fresh-bid-predator-Pfizer-approaches.html",
    "date": "2014-11-18",
    "keywords": [
        "pfizer",
        "soriot",
        "growth",
        "pipeline",
        "week",
        "number",
        "drugmaker",
        "group",
        "astra",
        "campaign",
        "bolton",
        "company",
        "business",
        "takeover",
        "offer",
        "plan",
        "tax",
        "cancer",
        "portfolio",
        "drug",
        "door",
        "progress",
        "trading",
        "london",
        "market",
        "investor",
        "daychief",
        "latestage",
        "track",
        "executive",
        "slump",
        "fray",
        "board",
        "approval",
        "year",
        "treatmentlike",
        "research",
        "development",
        "loss",
        "patent",
        "protection",
        "combat",
        "trend",
        "drugsagainst",
        "background",
        "merger",
        "rebuffed",
        "deadline",
        "inversion",
        "deal",
        "scupperedthe",
        "read",
        "meantime",
        "work",
        "treatment",
        "field",
        "immunotherapy",
        "bodys",
        "immune",
        "system",
        "effectivenesshe",
        "industry",
        "plannedastra",
        "filing",
        "date",
        "lung",
        "forecast",
        "plank",
        "bid",
        "defence",
        "pfizerthe",
        "heart",
        "brilinta",
        "japan",
        "half",
        "oncology",
        "platform",
        "part"
    ],
    "category": [
        "money",
        "markets"
    ]
}